Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides

FASEB Journal

Volumn 16, Issue 12, 2002, Pages 1526-1536

  Arispe, Nelson ^a,b   Doh, Michael ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

A P ion channels; Amyloid peptide; Calcium; Membrane interaction; Phosphatidylserine

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CYCLODEXTRIN; LIPOSOME; TROMETAMOL; ZINC ION;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL DEGENERATION; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOTOXICITY; NERVE CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; ANTICHOLESTEREMIC AGENTS; BETA-CYCLODEXTRINS; CELL MEMBRANE; CELL SURVIVAL; CHOLESTEROL; CYCLODEXTRINS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOSOMES; LOVASTATIN; PC12 CELLS; PEPTIDE FRAGMENTS; PHOSPHATIDYLSERINES; RATS; TROMETHAMINE; ZINC;

ANIMALIA;

EID: 0036793543     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0829com     Document Type: Article

References (63)

1. Yankner, B. A., Duffy, L. K., and Kirschner, D. A. (1990) Neurotrophic and neurotoxic effects of amyloid b protein: reversal by tachykinin neuropeptides. Science 250, 279-282
2. Selkoe, J. D. (2000) The origins of Alzheimer disease. A is for amyloid. J. Am. Med. Assoc. 238, 1615-1617
3. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. (1992) β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 379-389
4. Yankner, B. A. (1996) Mechanism of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932
5. Muller, W. E., Koch, S., Eckert, A., Hartmann, H., and Scheuer, K. (1995) β-amyloid peptide decreases membrane fluidity. Brain Res. 674, 133-136
6. Muller, W. E., Eckert, G. P., Scheuer, K., Cairns, N.J., Maras, A., and Gattaz, W. F.,. (1998) Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43. Amyloid 5, 10-15
7. Muller, W. E., Kirsch, C., and Eckert, G. P. (2001) Membrane-disordering effects of beta-amyloid peptides. Biochem. Soc. Trans. 29, 617-623
8. Mason, R. P., Estermyer, J. D., Kelly, J. F., and Mason, P. E. (1996) Alzheimer's disease amyloid β peptide 25-35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis. Biochem. Biophys. Res. Comm. 222, 78-82
9. Avdulov, N. A., Cochina, S. V., Igbavboa, U., Warden, C. S., Vassiliev, A. V., and Wood, W. G. (1997) Lipid binding to amyloid b-peptide aggregates. Preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J. Neurochem. 69, 1746-1752
10. Arispe, N., Rojas, E., and Pollard, H. B. (1993) Alzheimer disease amyloid β-protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90, 567-571
11. Arispe, N., Rojas, E., and Pollard, H. B. (1993) Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA 90, 10573-10577
12. 2+ interaction with Alzheimer amyloid β protein calcium channels. Proc. Natl. Acad. Sci. USA 93, 1710-1715
13. Galdzicki, Z., Fukuyama, R., Wadhwani, K., Rapoport, S., and Ehrenstein, G. (1994) β-amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease. Brain Res. 646, 332-336
14. 2+-sensitive cation-selective channels across excited membrane patches from hypothalamic neurons. Biophys. J. 73, 67-75
15. +2 sensitive channels. J. Biol. Chem. 273, 13379-13382
16. 2+ sensitive channels in reconstituted lipid vesicles. Biochemistry 38, 11189-11196
17. Hirakura, Y., Lin, M. C., and Kagan, B. L. (1999) Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red. J. Neurosci. Res. 57, 458-66
18. Koh, J. Y., Yang, L. L., and Cotman, C. W. (1990) β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320
19. 2+ channel activity by β-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. J. Biol. Chem. 275, 4713-4718
20. Lee, K. Y. C. (2001) Interactions of Alzheimer's amyloid-betapeptides with lipid membranes. Biophys. J. 80, 23a (abstr.)
21. Vargas, J., Alarcon, J. M., and Rojas, E. (2000) Displacement currents associated with the insertion of Alzheimer disease amyloid β-peptide into planar bilayer membranes Biophys. J. 79, 934-944
22. 2+-channel hypothesis for neuronal death in Alzheimer disease. Mol. Cell. Biochem. 140, 119-125
23. Simmons, M. A., and Schneider, C. R. (1993) Amyloid β peptides act directly on single neurons. Neurosci. Lett. 150, 133-136
24. Furukawa, K., Abe, Y., and Akaike, N. (1994) Amyloid β protein-induced irreversible current in rat cortical neurones. NeuroReport 5, 2016-2018
25. Mirzabekov, T., Lin, M. C., Yuan, W. L., Marshall, P.J., Carman, M., Tomaselli, K., Lieberburg, I., and Kagan, B. L. (1994) Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide. Biochem. Biophys. Res. Commun. 202, 1142-1148
26. Hirakura, Y., Yiu, W. W., Yamamoto, A., and Kagan, B. L. (2000) Amyloid peptide channels: blockade by zinc and inhibition by Congo red. Amyloid 7, 194-199
27. Bhathia, R., Lin, H., and Lal, R. (2000) Fresh and globular amyloid b protein induces rapid cellular degeneration. A possible implication for calcium-uptake via AβP-channel. FASEB J. 14, 1233-1243
28. Zhu, Y. J., Lin, H., and Lal, R. (2000) Fresh and nonfibrillar amyloid β protein (1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP-channel-mediated cellular toxicity. FASEB J. 14, 1244-1254
29. Lin, H., Bhatia, R., and Lal, R. (2001) Amyloid protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15, 2433-2444
30. Lin, M. C., and Kagan, B. (2002) Electrophysiologic properties of channels induced by Aβ25-35 in planar lipid bilayers. Peptides In press
31. Eckert, G. P., Kirsch, C., and Muller, W. E. (2001) Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice. NeuroReport 12, 883-887
32. Chochina, S. V., Avdulov, N. A., Igbavboa, U., Cleary, J. P., O'Hare, E. O., and Wood, W. G. (2001) Amyloid beta-peptidel-40 increases neuronal membrane fluidity: role of cholesterol and brain region. J. Lipid Res. 42, 1292-1297
33. Kawahara, M., Arispe, N., Kuroda, Y., and Rojas, E. (2000) Alzheimer's b-amyloid, Human Amylin and Prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275, 14077-14083
34. Kawahara, M., and Kuroda, Y. (2001) Intracellular calcium changes in neuronal cells induced by Alzheimer's beta-amyloid protein are blocked by estradiol and cholesterol. Cell. Mol. Neurobiol. 21, 1-13
35. Lee, G., Pollard, H. B., and Arispe, N. (2002) Annexin 5 and apolipoprotein E2 protect against Alzheimer's amyloid β peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site. Peptides In press
36. Arispe, N. (2001a) Control of the interaction of the Alzheimer's AβPs, and homologous analogues, with lipid membranes. Biophys. J. 80, 135-136
37. Arispe, N. J., McKinney, L. C., and Doh, M. (2001b) Testing the ion channel hypothesis for Alzheimer's AβP neurotoxicity on PC12 cells. Soc. Neurosci. Abstr. 27, program no. 962.15
38. Arispe, N. J., and Doh, M. (2002) A test to the ion channel hypothesis for Alzheimer's AβP neurotoxicity on PC12 cells. Biophys. J. 82, 17a (abstr.)
39. Neufeld, E. B., Cooney, A. M., Pitha, J., Dawidowicz, E. A., Dwyer, N. K., Pentchev, P. G., and Blanchette-Mackie, J. (1996) Intracellular trafficking of cholesterol monitored with a cyclodextrin. J. Biol. Chem.. 271, 21604-21613
40. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., and Simons, K. (1998) Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA 95, 6460-6464
41. Simons, M., Keller, P., Dichgans, J., and Schulz, J. B. (2001) Cholesterol and Alzheimer's disease. Is there a link? Neurology 57, 1089-1093
42. Hansen, G. H., Niels-Christiansen, L. L., Thorsen, E., Immerdal, L., and Danielsen, M. (2000) Cholesterol depletion of enterocytes. Effect on the Golgi complex and apical membrane trafficking. J. Biol. Chem. 275, 5136-5142
43. Endo, A. (1992) The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33, 1569-1582
44. Racchi, M., Baetta, R., Salvietti, N., Ianna, P., Franceschini, G., Paoletti, R., Fumagalli, R., Govoni, S., Trabucchi, M., and Soma, M. (1997) Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem. J. 322, 893-898
45. Furuchi, T., and Anderson, R. G. W. (1998) Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol. Chem. 273, 21099-21104
46. Yancey, P. G., Rodrigueza, W. V., Kilsdonk, P. C., Stoudt, G. W., Johnson, W. J., Phillips, M. C., and Rothblat, G. H. (1996) Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 271, 16026-16034
47. Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Luthjohann, D., Keller, P., Runz, H., Kulh, S., Bertsch, T., von Bergmann, K., Hennerici, M., Beyreuther, K., and Hartmann, T. (2001) Simvastatin strongly reduces levels of Alzheimer's disease [beta]-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98, 5856-5861
48. Kojro, E., Gimpl, G., Lammich, S., Marz, W., and Farenholz, F. (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. USA 98, 5815-5820
49. Lundbaek, J. A., Birn, P., Girshman, J., Hansen, A. J., and Anderson, O. S. (1996) Membrane stiffness and channel function. Biochemistry 35, 3825-3830
50. Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smith-Swintosky, V. L., and Rydel, R. E. (1993) β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-415
51. Durrell, S. R., Guy, H. R., Arispe, N., Rojas, E., and Pollard, H. B. (1994) Theoretical models of the ion channel structure of amyloid-β-protein. Biophys. J. 67, 2137-2145
52. Kourie, J. I., Shorthouse, A. A. (2000) Properties of cytotoxic peptide-formed ion channels. Am. J. Physiol. 278, C1063-C1087
53. Kourie, J. I. (2001) Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases. Cell. Mol. Neurobiol. 21, 173-213
54. Bodovitz, S., and Kelin, W. L. (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436-4440
55. Lütjohann, D., Papassotiropoulus, A., Björkhem, I., Locatelli, S., Bagli, M., Oehring, R., Schlegel, U., Jessen, F., Rao, M. L., Bergmann, K., and Heun, R. (2000) Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41, 195-198
56. Dea, D., Lamarre-theroux, L., Aumont, N., and Poirier, J. (2001) Abnormal splicing of the 3-hydroxy-3-methylglutaryl coenzyme A reductase in the brain of sporadic Alzheimer's disease subjects. Soc. Neurosci. Abstr. 27, program no. 192.5
57. Bi, X., Zhou, J., Sharman, K., Song, Z., Liu, J., and Lynch, G. (2001) Induction of Alzheimer's disease type pathologies in cultured hippocampal slices by cholesterol depletion. Soc. Neurosci. Abstr. 27, program no. 963.17
58. Klein, U., Gimpl, G., and Fahrenholz, F. (1995) Alteration of the myometrial plasma membrane cholesterol content with β-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34, 13784-13793
59. Pang, L., Graziano, M., and Wang, S. (2011) (1999) Membrane cholesterol modulates galanin-GalR2 interaction. Biochemistry 38, 12003-12011
60. Zhou, Y., and Richardson, J. S. (1996) Cholesterol protects PC12 cells from β-amyloid induced calcium disordering and cytotoxicity. NeuroReport 7, 2487-2490
61. Howland, D. S., Trusko, S. P., Savage, M. J., Reaume, A. G., Lang, D. M., Hirsch, J. D., Maeda, N., Siman, R., Greenberg, B. D., Scott, R. W., and Flood, D. G. (1998) J. Biol. Chem. 273, 16576-16582
62. Mirzabekov, T. A., Lin M-C, and Kagan, B. (1996) Pore formation by the cytotoxic islet amyloid peptide amylin. J. Biol. Chem. 271, 1988-1992
63. Mason, R. P., Shoemaker, W.J., Shajenko, L., Chambers, T. E., and Herbette, L. G. (1992) Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol. Neurobiol. Aging 13, 413-419